annual interest expense:
$98.52M-$9.72M(-8.98%)Summary
- As of today (June 3, 2025), BCRX annual interest expense is $98.52 million, with the most recent change of -$9.72 million (-8.98%) on December 31, 2024.
- During the last 3 years, BCRX annual interest expense has risen by +$39.22 million (+66.15%).
- BCRX annual interest expense is now -8.98% below its all-time high of $108.24 million, reached on December 31, 2023.
Performance
BCRX Interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly interest expense:
$23.49M-$955.00K(-3.91%)Summary
- As of today (June 3, 2025), BCRX quarterly interest expense is $23.49 million, with the most recent change of -$955.00 thousand (-3.91%) on March 31, 2025.
- Over the past year, BCRX quarterly interest expense has dropped by -$1.01 million (-4.13%).
- BCRX quarterly interest expense is now -18.75% below its all-time high of $28.91 million, reached on June 30, 2023.
Performance
BCRX quarterly interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM interest expense:
$97.50M-$1.01M(-1.03%)Summary
- As of today (June 3, 2025), BCRX TTM interest expense is $97.50 million, with the most recent change of -$1.01 million (-1.03%) on March 31, 2025.
- Over the past year, BCRX TTM interest expense has dropped by -$7.84 million (-7.45%).
- BCRX TTM interest expense is now -11.45% below its all-time high of $110.11 million, reached on September 30, 2023.
Performance
BCRX TTM interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Interest expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
BCRX Interest expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.0% | -4.1% | -7.5% |
| 3 y3 years | +66.2% | -1.4% | +38.8% |
| 5 y5 years | +728.4% | +671.0% | +698.4% |
BCRX Interest expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -9.0% | +66.2% | -18.8% | at low | -11.4% | +38.8% |
| 5 y | 5-year | -9.0% | +728.4% | -18.8% | +705.1% | -11.4% | +706.1% |
| alltime | all time | -9.0% | >+9999.0% | -18.8% | >+9999.0% | -11.4% | >+9999.0% |
BCRX Interest expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $23.49M(-3.9%) | $97.50M(-1.0%) |
| Dec 2024 | $98.52M(-9.0%) | $24.45M(-1.5%) | $98.52M(-0.1%) |
| Sep 2024 | - | $24.83M(+0.4%) | $98.65M(-2.5%) |
| Jun 2024 | - | $24.73M(+0.9%) | $101.17M(-4.0%) |
| Mar 2024 | - | $24.51M(-0.3%) | $105.35M(-2.7%) |
| Dec 2023 | $108.24M(+9.2%) | $24.58M(-10.1%) | $108.24M(-1.7%) |
| Sep 2023 | - | $27.34M(-5.4%) | $110.11M(+2.4%) |
| Jun 2023 | - | $28.91M(+5.5%) | $107.54M(+4.8%) |
| Mar 2023 | - | $27.40M(+3.5%) | $102.65M(+3.6%) |
| Dec 2022 | $99.09M(+67.1%) | $26.46M(+6.8%) | $99.09M(+8.4%) |
| Sep 2022 | - | $24.77M(+3.1%) | $91.41M(+13.2%) |
| Jun 2022 | - | $24.02M(+0.8%) | $80.75M(+15.0%) |
| Mar 2022 | - | $23.84M(+26.9%) | $70.23M(+18.4%) |
| Dec 2021 | $59.29M(+308.9%) | $18.78M(+33.0%) | $59.29M(+28.6%) |
| Sep 2021 | - | $14.12M(+4.6%) | $46.12M(+30.9%) |
| Jun 2021 | - | $13.49M(+4.6%) | $35.25M(+42.9%) |
| Mar 2021 | - | $12.90M(+130.1%) | $24.67M(+66.5%) |
| Dec 2020 | $14.50M(+21.9%) | $5.61M(+73.2%) | $14.81M(+20.5%) |
| Sep 2020 | - | $3.24M(+11.0%) | $12.29M(+1.6%) |
| Jun 2020 | - | $2.92M(-4.2%) | $12.10M(-1.0%) |
| Mar 2020 | - | $3.05M(-1.3%) | $12.21M(+2.7%) |
| Dec 2019 | $11.89M(+29.6%) | $3.09M(+1.4%) | $11.89M(+6.0%) |
| Sep 2019 | - | $3.04M(+0.3%) | $11.22M(+6.6%) |
| Jun 2019 | - | $3.04M(+11.3%) | $10.52M(+8.7%) |
| Mar 2019 | - | $2.73M(+12.9%) | $9.68M(+5.5%) |
| Dec 2018 | $9.18M(+7.1%) | $2.41M(+2.9%) | $9.18M(+2.0%) |
| Sep 2018 | - | $2.35M(+6.9%) | $8.99M(+2.3%) |
| Jun 2018 | - | $2.19M(-1.2%) | $8.79M(+1.2%) |
| Mar 2018 | - | $2.22M(-0.4%) | $8.69M(+1.4%) |
| Dec 2017 | $8.56M | $2.23M(+4.3%) | $8.56M(+1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $2.14M(+2.2%) | $8.46M(+8.7%) |
| Jun 2017 | - | $2.09M(-0.3%) | $7.79M(+9.5%) |
| Mar 2017 | - | $2.10M(-1.5%) | $7.12M(+9.7%) |
| Dec 2016 | $6.49M(+24.8%) | $2.13M(+45.5%) | $6.49M(+13.9%) |
| Sep 2016 | - | $1.47M(+3.1%) | $5.69M(+4.1%) |
| Jun 2016 | - | $1.42M(-3.3%) | $5.47M(+2.1%) |
| Mar 2016 | - | $1.47M(+9.9%) | $5.36M(+3.0%) |
| Dec 2015 | $5.20M(+4.0%) | $1.34M(+7.8%) | $5.20M(+0.5%) |
| Sep 2015 | - | $1.24M(-5.0%) | $5.18M(+0.5%) |
| Jun 2015 | - | $1.31M(-0.7%) | $5.15M(+1.6%) |
| Mar 2015 | - | $1.31M(+0.1%) | $5.07M(+1.5%) |
| Dec 2014 | $5.00M(+4.6%) | $1.31M(+8.0%) | $5.00M(+1.5%) |
| Sep 2014 | - | $1.22M(-0.7%) | $4.93M(+0.5%) |
| Jun 2014 | - | $1.23M(-1.4%) | $4.90M(+1.2%) |
| Mar 2014 | - | $1.24M(0.0%) | $4.84M(+1.3%) |
| Dec 2013 | $4.78M(+2.4%) | $1.24M(+4.3%) | $4.78M(+1.3%) |
| Sep 2013 | - | $1.19M(+2.2%) | $4.72M(+0.5%) |
| Jun 2013 | - | $1.17M(-1.3%) | $4.69M(+0.1%) |
| Mar 2013 | - | $1.18M(0.0%) | $4.69M(+0.4%) |
| Dec 2012 | $4.67M(+23.6%) | $1.18M(+1.2%) | $4.67M(+0.4%) |
| Sep 2012 | - | $1.17M(+0.5%) | $4.65M(+0.1%) |
| Jun 2012 | - | $1.16M(0.0%) | $4.64M(-0.1%) |
| Mar 2012 | - | $1.16M(0.0%) | $4.65M(+23.1%) |
| Dec 2011 | $3.77M(>+9900.0%) | $1.16M(0.0%) | $3.77M(+44.4%) |
| Sep 2011 | - | $1.16M(-0.5%) | $2.61M(+79.8%) |
| Jun 2011 | - | $1.17M(+304.9%) | $1.45M(+404.9%) |
| Mar 2011 | - | $288.00K(>+9900.0%) | $288.00K(>+9900.0%) |
| Dec 2010 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00 | $0.00 |
FAQ
- What is BioCryst Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual interest expense year-on-year change?
- What is BioCryst Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly interest expense year-on-year change?
- What is BioCryst Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM interest expense year-on-year change?
What is BioCryst Pharmaceuticals annual interest expense?
The current annual interest expense of BCRX is $98.52M
What is the all time high annual interest expense for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual interest expense is $108.24M
What is BioCryst Pharmaceuticals annual interest expense year-on-year change?
Over the past year, BCRX annual interest expense has changed by -$9.72M (-8.98%)
What is BioCryst Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of BCRX is $23.49M
What is the all time high quarterly interest expense for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly interest expense is $28.91M
What is BioCryst Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, BCRX quarterly interest expense has changed by -$1.01M (-4.13%)
What is BioCryst Pharmaceuticals TTM interest expense?
The current TTM interest expense of BCRX is $97.50M
What is the all time high TTM interest expense for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM interest expense is $110.11M
What is BioCryst Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, BCRX TTM interest expense has changed by -$7.84M (-7.45%)